Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?
Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
Search results for "U.S."
Robot-Assisted Operations Account for 1 in 5 Stomach Cancer Surgeries at Samsung Medical Center as Milestone Hits 1,500
Samsung Medical Center has performed more than 1,500 robot-assisted stomach cancer surgeries, reaching the milestone 16 years after introducing the...
SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs
SK Plasma announced on Sept. 1 that it has begun distributing Revolpag Tablets 75 mg in South Korea, expanding its...
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits
Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct...
Stopping Beta-Blockers After Heart Attack Safe for Stable Patients, Korea-France Study Finds
One medication many patients take long-term following a heart attack is a beta-blocker.
Scarlett Johansson’s Nightly Sleep Secret: Can Magnesium Really Transform Your Skin?
Hollywood star Scarlett Johansson, 41, has long drawn attention for her approach to health and wellness.
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry...
Hanmi Licenses Muscle-Preserving Obesity Drug Candidate to Genentech in $2.3 Billion Deal
Hanmi Pharmaceutical has entered into an exclusive global licensing agreement with Genentech, a member of the Roche...
“Miracle” Eye Supplements Can’t Cure Glaucoma or Cataracts, Ophthalmologists Warn
“Lowers intraocular pressure to improve glaucoma and cataracts. ” “Prevents macular degeneration.
Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits
The arrival of disease-modifying treatments capable of slowing Alzheimer’s progression has offered patients newfound...